The Research and Development team at Bold Therapeutics Inc. focuses on advancing preclinical and clinical-stage cancer therapies. This multidisciplinary team is responsible for developing novel combinations of existing anti-cancer therapies, optimizing drug formulations, performing computational biology analyses, and coordinating preclinical studies to support the efficacy and safety of Bold Therapeutics' innovative treatments.
View all